Equine Healthcare Market
Global equine healthcare market was valued at $ 2.1 billion in 2022 and is likely to reach $ 3.8 billion by 2032, registering a CAGR of 5.6% over the forecast period of 2023-2032. Equine healthcare encompasses an approach, to ensuring the well-being of horses. It combines care, nutrition and preventive measures to optimize the health and performance of these creatures. With the horse population on the rise due to their involvement in activities such as recreation, sports, therapy and companionship there is an increasing demand for specialized healthcare solutions. This growth not expands the market. Also highlights the responsibility of horse owners to prioritize their equine companion’s health and well-being.
The diverse needs of this growing population have led to an increased demand, for services, pharmaceuticals, nutritional supplements and preventive care solutions. To cater to this shift manufacturers and service providers are adapting their offerings accordingly to meet the evolving requirements of an equine clientele while sustaining the vitality and longevity of these majestic animals. Essentially the increasing number of horses not boosts the demand, for equine healthcare products but also highlights the industry’s dedication to offering customized and comprehensive solutions to cater to the varied healthcare requirements of horses, across the globe.
Source: Secondary Research, Primary Research, MRP Database and Analyst Review
The increasing focus, on the well-being of companion animals horses viewed as valued companions is driving the sales of equine healthcare products. Of being seen as working animals horses are now considered cherished companions and important members of families. This new perspective has brought about a shift in horse ownership practices with owners becoming more committed to the health and happiness of these creatures.
This change in mind-set has created a growing demand for specialized equine healthcare solutions that go beyond care. Horse owners, who now see their equine partners as pets are seeking wellness programs, nutritional supplements and preventive healthcare measures to improve the quality of life for their four legged friends. In response to this shift in perception the equine healthcare market is offering tailored products and services that align with the values of companion animal well-being. Manufacturers and service providers recognize the connection, between humans and horses. Strategically position their offerings to meet the evolving needs of horse owners who prioritize the holistic well-being of their equine companions.
Essentially the increasing focus, on the well-being of companion animals acts as a catalyst. It not boosts the sales of healthcare products for horses. Also nurtures a stronger bond, between horse owners and the products created to improve the health of their beloved equine companions. The continuous strides in veterinary medicine constitute a compelling force propelling the ascent of the equine healthcare market. Advancements in diagnostics, pharmaceuticals, and surgical techniques are revolutionizing the landscape of equine healthcare, offering unprecedented avenues to enhance the well-being of horses. This progress not only ensures more accurate diagnoses and effective treatments but also opens new possibilities for preventive care and innovative therapeutic interventions.
The advancements, in medicine have led to an advanced and nuanced approach to horse healthcare creating an environment that encourages increased sales. Veterinarians now have access to cutting edge technologies and therapeutic methods enabling them to address the health needs of horses. This instils confidence among horse owners.
The market response to these advances is clear with an increase in demand for healthcare products and services that make use of the latest breakthroughs in veterinary medicine. There is a growing interest in innovations targeted therapies and diagnostic tools specifically designed for equine health. This contributes to a market ecosystem. In this era of progress manufacturers and healthcare providers play a role, in aligning their offerings with the latest veterinary innovations. By doing they not meet the evolving demands of horse owners but also boost sales by providing solutions that showcase the forefront of veterinary medicines ability to optimize the health and lifespan of horses.
Equine healthcare Market Overview
Market Attributes |
Details |
Market Size in 2022 |
$ 2.1 billion |
Market Size in 2032 |
$ 3.8 billion |
Forecast Period |
2023-2032 |
CAGR |
5.6% |
Market Dynamics |
· Drivers o Rising Equine Population o Growing Awareness of Preventive Care · Restraints o Limited Awareness Among Horse Owners o Resistance to Change · Opportunities o Global Market Expansion o Educational Initiatives |
Segments Covered in the report |
· By Product Type o Vaccines o Medicinal Feed Additives o Diagnostics o Software & Services o Others · By Healthcare Induction o Musculoskeletal Disorders o Parasite Control o Internal Medicine o Equine Herpes Virus o Others · By Healthcare Activity o Sports/Racing o Recreation o Others |
Regions Covered in the Report |
· North America o U.S. o Canada o Mexico · Latin America o Brazil o Argentina o Rest of Latin America · Europe o Germany o UK o France o Russia o Italy o Spain o Rest of Europe · Asia-Pacific o China o Japan o India o South Korea o Australia o Rest of Asia-Pacific · Middle East & Africa o Israel o UAE o Saudi Arabia o Iran o Rest of MEA |
Companies |
· Zoetis · Boehringer Ingelheim International GmbH · Ceva · MERCK & CO., INC. · Hallmarq Veterinary Imaging · ESAOTE SPA · Vetoquinol S.A. · IDEXX Laboratories, Inc. · Dechra Pharmaceuticals PLC |
1: Introduction
1.1 Report Description
1.2 Overview of Equine Healthcare
1.3 Evolution and Advancements in Equine Healthcare
1.4 Market Segmentation and Scope
1.5 Research Methodology
2: Executive Summary
2.1 Key Findings
2.2 Market Trends and Insights
2.3 Key Market Players
2.4 Future Outlook
3: Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
3.3 Market Opportunities
3.4 Porter's Five Forces Analysis
3.5 Value Chain Analysis
3.6 Impact of COVID-19 on the Equine Healthcare Market
4: Equine Healthcare Market, by Product Type
4.1 Overview
4.2 Vaccines
4.2.1 Key Market Trends
4.2.2 Market Size, 2022-2032
4.3 Medicinal Feed Additives
4.3.1 Key Market Trends
4.3.2 Market Size, 2022-2032
4.4 Diagnostics
4.4.1 Key Market Trends
4.4.2 Market Size, 2022-2032
4.5 Software & Services
4.5.1 Key Market Trends
4.5.2 Market Size, 2022-2032
4.6 Others
4.6.1 Key Market Trends
4.6.2 Market Size, 2022-2032
5: Equine Healthcare Market, by Healthcare Induction
5.1 Musculoskeletal Disorders
5.1.1 Key Market Trends
5.1.2 Market Size, 2022-2032
5.2 Parasite Control
5.2.1 Key Market Trends
5.2.2 Market Size, 2022-2032
5.3 Internal Medicine
5.3.1 Key Market Trends
5.3.2 Market Size, 2022-2032
5.4 Equine Herpes Virus
5.4.1 Key Market Trends
5.4.2 Market Size, 2022-2032
5.5 Others
5.5.1 Key Market Trends
5.5.2 Market Size, 2022-2032
6: Equine Healthcare Market, by Healthcare Activity
6.1 Sports/Racing
6.1.1 Key Market Trends
6.1.2 Market Size, 2022-2032
6.2 Recreation
6.2.1 Key Market Trends
6.2.2 Market Size, 2022-2032
6.3 Others
6.3.1 Key Market Trends
6.3.2 Market Size, 2022-2032
7: Regional Analysis
7.1 North America
7.1.1. U.S.
7.1.2 Canada
7.1.3 Mexico
7.2 Latin America
8.2.1 Brazil
8.2.2 Argentina
8.2.3 Rest of Latin America
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Russia
8.3.5 Italy
8.3.6 Spain
8.3.7 Rest of Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Israel
8.5.2 UAE
8.5.3 Saudi Arabia
8.5.4 Iran
8.5.5 Rest of MEA
9: Competitive Landscape
9.1 Zoetis
9.1.1 Overview
9.1.2 Product Portfolio
9.1.3 Financial Performance
9.1.4 Recent Developments
9.2 Boehringer Ingelheim International GmbH
9.2.1 Overview
9.2.2 Product Portfolio
9.2.3 Financial Performance
9.2.4 Recent Developments
9.3 Ceva
9.3.1 Overview
9.3.2 Product Portfolio
9.3.3 Financial Performance
9.3.4 Recent Developments
9.4 MERCK & CO., INC.
9.4.1 Overview
9.4.2 Product Portfolio
9.4.3 Financial Performance
9.4.4 Recent Developments
9.5 Hallmarq Veterinary Imaging
9.5.1 Overview
9.5.2 Product Portfolio
9.5.3 Financial Performance
9.5.4 Recent Developments
9.6 ESAOTE SPA
9.6.1 Overview
9.6.2 Product Portfolio
9.6.3 Financial Performance
9.6.4 Recent Developments
9.7 Vetoquinol S.A.
9.7.1 Overview
9.7.2 Product Portfolio
9.7.3 Financial Performance
9.7.4 Recent Developments
9.8 IDEXX Laboratories, Inc.
9.8.1 Overview
9.8.2 Product Portfolio
9.8.3 Financial Performance
9.8.4 Recent Developments
9.9 Dechra Pharmaceuticals PLC
9.9.1 Overview
9.9.2 Product Portfolio
9.9.3 Financial Performance
9.9.4 Recent Developments
10: Investment Analysis
11: Market Opportunity and Trends